Open Insider Trading Activity for Alnylam Pharmaceuticals, Inc. EVP, Chief Financial Officer Poulton Jeffrey V.
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting ALNY | 2026-03-06 | 2026-03-04 | Alnylam Pharmaceuticals, Inc. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | 8 | 2,468 | $323.08 | $797,350.54 | 0.49% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting ALNY | 2026-03-04 | 2026-03-02 | Alnylam Pharmaceuticals, Inc. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | 10 | 2,206 | $327.65 | $722,800.78 | 0.34% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting ALNY | 2026-01-14 | 2026-01-12 | Alnylam Pharmaceuticals, Inc. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | 21 | 2,780 | $362.87 | $1,008,765.87 | 0.23% | View Filing |